ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer Last updated on Jun 5, 2026 Previous SORAYA: Mirvetuximab Soravtansine in FRα-High Platinum-Resistant Ovarian Cancer Next Trastuzumab in HER2-Positive Uterine Serous Carcinoma (Fader)
